These findings suggest that the increased risk of pregnancy complications in obstetric APS patients may be due, at least in part, to alterations in trophoblast function upon stimulation with aPL and, more importantly, to the resulting release of EVs with altered cargo. The gene discussed is FASLG; the disease is autoimmune polyendocrinopathy.